BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $252 | +21.2% | 40,744 | -0.7% | 0.00% | 0.0% |
Q1 2024 | $208 | -20.9% | 41,032 | -6.4% | 0.00% | -50.0% |
Q4 2023 | $263 | -30.8% | 43,827 | -18.3% | 0.00% | -33.3% |
Q3 2023 | $380 | +5.6% | 53,640 | +4.9% | 0.00% | +50.0% |
Q2 2023 | $360 | -24.8% | 51,121 | -11.0% | 0.00% | -33.3% |
Q1 2023 | $479 | -25.6% | 57,430 | +2.4% | 0.00% | -40.0% |
Q4 2022 | $644 | -99.9% | 56,078 | -8.1% | 0.01% | -16.7% |
Q3 2022 | $769,000 | +153.0% | 61,051 | +112.4% | 0.01% | +200.0% |
Q2 2022 | $304,000 | -48.6% | 28,741 | -20.9% | 0.00% | -33.3% |
Q1 2022 | $591,000 | +24.9% | 36,342 | +6.4% | 0.00% | +50.0% |
Q4 2021 | $473,000 | +19.1% | 34,141 | +23.6% | 0.00% | 0.0% |
Q3 2021 | $397,000 | +9.7% | 27,631 | +20.5% | 0.00% | 0.0% |
Q2 2021 | $362,000 | +82.8% | 22,923 | +17.8% | 0.00% | +100.0% |
Q1 2021 | $198,000 | +67.8% | 19,465 | +23.1% | 0.00% | 0.0% |
Q4 2020 | $118,000 | +45.7% | 15,813 | +12.5% | 0.00% | 0.0% |
Q2 2018 | $81,000 | -22.1% | 14,060 | -35.4% | 0.00% | 0.0% |
Q1 2018 | $104,000 | -32.9% | 21,773 | -31.1% | 0.00% | 0.0% |
Q4 2017 | $155,000 | +573.9% | 31,595 | +284.2% | 0.00% | – |
Q2 2016 | $23,000 | +4.5% | 8,224 | +8.1% | 0.00% | – |
Q1 2016 | $22,000 | -60.0% | 7,609 | +42.5% | 0.00% | – |
Q4 2015 | $55,000 | -32.1% | 5,341 | -24.8% | 0.00% | -100.0% |
Q3 2015 | $81,000 | +145.5% | 7,106 | +217.5% | 0.00% | – |
Q2 2015 | $33,000 | +106.2% | 2,238 | +28.5% | 0.00% | – |
Q1 2015 | $16,000 | -23.8% | 1,742 | +0.2% | 0.00% | – |
Q4 2014 | $21,000 | +5.0% | 1,739 | -14.0% | 0.00% | – |
Q3 2014 | $20,000 | -4.8% | 2,022 | +22.0% | 0.00% | – |
Q2 2014 | $21,000 | +16.7% | 1,657 | 0.0% | 0.00% | – |
Q1 2014 | $18,000 | +50.0% | 1,657 | +1.5% | 0.00% | – |
Q4 2013 | $12,000 | – | 1,633 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |